These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23078546)

  • 41. Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.
    Kikuchi W; Ichihara K; Mori K; Shimizu Y
    Ann Clin Biochem; 2021 Jul; 58(4):358-367. PubMed ID: 33715446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone responsiveness to parathyroid hormone is negatively associated with parathyroid hormone-lowering drug use in patients undergoing hemodialysis: a cross-sectional study.
    Tominaga N; Yonaha T; Yamanouchi M; Sumi H; Taki Y; Shibagaki Y; Shiizaki K; Yano S
    BMC Nephrol; 2021 Aug; 22(1):275. PubMed ID: 34372813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new approach for evaluating bone turnover in chronic kidney disease.
    Tolouian R; Hernandez GT; Chiang WY; Gupta A
    Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women.
    Bonjour JP; Benoit V; Payen F; Kraenzlin M
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2915-21. PubMed ID: 23653431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
    Ohashi T; Igarashi Y; Mochizuki Y; Miura T; Inaba N; Katayama K; Tomonaga T; Nomura F
    Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients.
    Ishimura E; Okuno S; Okazaki H; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
    Kidney Blood Press Res; 2014; 39(4):299-307. PubMed ID: 25300371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA; Clowes JA; Eagleton AC; Al Hadari A; Eastell R; Blumsohn A
    Bone; 2004 Jan; 34(1):187-94. PubMed ID: 14751577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
    Chao TY; Yu JC; Ku CH; Chen MM; Lee SH; Janckila AJ; Yam LT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):544-50. PubMed ID: 15701839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism.
    Yano S; Suzuki K; Sumi M; Tokumoto A; Shigeno K; Himeno Y; Sugimoto T
    J Bone Miner Metab; 2010; 28(1):49-54. PubMed ID: 19548062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
    Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
    J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kidney transplantation restored uncoupled bone turnover in end-stage renal disease.
    Kawarazaki H; Shibagaki Y; Kido R; Nakajima I; Fuchinoue S; Ando K; Fujita T; Fukagawa M; Teraoka S; Fukumoto S
    Clin Nephrol; 2012 Jul; 78(1):10-6. PubMed ID: 22732332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
    Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary excretion of type I collagen cross-linked N-telopeptide and serum bone-specific alkaline phosphatase analysis to determine the correlation of age and back-pain related changes in elderly women.
    Kamimura M; Uchiyama S; Takahara K; Hashidate H; Kawaguchi A; Nakagawa H
    J Bone Miner Metab; 2005; 23(6):495-500. PubMed ID: 16261458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
    Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G
    J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
    Janckila AJ; Lederer ED; Price BA; Yam LT
    Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
    Jung K; Lein M; Ringsdorf M; Roigas J; Schnorr D; Loening SA; Staack A
    J Urol; 2006 Oct; 176(4 Pt 1):1326-31. PubMed ID: 16952623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab].
    Tatekoshi A; Sato T; Ibata S; Hashimoto A; Kamihara Y; Horiguchi H; Ono K; Takada K; Iyama S; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2014 Nov; 55(11):2271-6. PubMed ID: 25501406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TRACP 5b and CTX as osteological markers of delayed fracture healing.
    Moghaddam A; Müller U; Roth HJ; Wentzensen A; Grützner PA; Zimmermann G
    Injury; 2011 Aug; 42(8):758-64. PubMed ID: 21168135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
    Terpos E; Viniou N; de la Fuente J; Meletis J; Voskaridou E; Karkantaris C; Vaiopoulos G; Palermos J; Yataganas X; Goldman JM; Rahemtulla A
    Eur J Haematol; 2003 Jan; 70(1):34-42. PubMed ID: 12631257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.